Core 03: Tumor Imaging Metrics

肿瘤影像指标共享资源 项目摘要/摘要 肿瘤影像指标核心为患者提供对肿瘤治疗反应的客观评估 参加肿瘤学临床试验。支持所有主要的放射评估标准，包括：RECIST (1.0和1.1)、切森(2007和2009)、IWCLL、RANO、PET SUV、PCWG2、Choi、3D Volume和IRRC。为 根据评估标准指南选择每个患者、目标和非目标皮损 都是纵向追踪的。用户可以随时随地登录网站访问数据和 订购扫描分析请求。定量分析的CT，MR和正电子发射计算机断层扫描研究 各种型号特定的工作站。分析扫描后，查看测量结果 并由哈佛大学教员放射学家和/或核医学内科医生最终确定。测量结果为 存储在安全网站上的Core数据库中，并可由经授权的试验工作人员在线查看。这个 定量测量用于确定肿瘤对治疗的反应并最终指导患者 关心。试验的汇总统计数据以及单个患者的测量数据都提供了出来。差饷 与DF/HCC外部提供的其他选择相比，服务非常合理。

Tumor Imaging Metrics Shared Resource Project Summary / Abstract The Tumor Imaging Metrics Core provides objective assessment of tumor response to treatment for patients enrolled in oncology clinical trials. All major radiological assessment criteria are supported including: RECIST (1.0 and 1.1), Cheson (2007 and 2009), IWCLL, RANO, PET SUV, PCWG2, Choi, 3D Volume, and irRC. For each patient, target and non-target lesions are selected according to the assessment criteria guidelines and are tracked longitudinally. Users are able to log into the website from anywhere at any time to access data and order a request for scan analysis. Quantitative analysis of CT, MR, and PET imaging studies are performed on a variety of modality-specific workstations. After scans are analyzed, the measurement results are reviewed and finalized by Harvard faculty radiologists and/or nuclear medicine physicians. Measurement results are stored in the Core database on a secure website and are viewable online by authorized trial staff. The quantitative measurements are used to determine tumor response to treatment and ultimately guide patient care. Summary statistics for the trial are presented as well as individual patient measurements. Rates for services are very reasonable compared to other options available from outside DF/HCC.